Talaris Therapeutics, Inc. Business Finance Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Capital Stock and Anti-Takeover Provisions under Certificate of Incorporation and Bylaws
Stock Agreements
Talaris Therapeutics, Inc.
Biotechnology
2024
Underwriting Agreement between Tourmaline Bio, Inc. and Jefferies LLC, Piper Sandler & Co., Guggenheim Securities, LLC, and Truist Securities, Inc. (January 25, 2024)
Underwriting Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2024
Tourmaline Bio, Inc. 2023 Employee Stock Purchase Plan
Equity Distribution Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Tourmaline Bio, Inc. 2023 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Talaris Therapeutics, Inc.
Biotechnology
2023
Tourmaline Bio, Inc. Stock Option Grant Notice and Agreement (2023 Equity Incentive Plan)
Equity Distribution Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Tourmaline Bio, Inc. 2023 Equity Incentive Plan
Equity Distribution Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2023
Tourmaline Bio, Inc. 2022 Equity Incentive Plan
Equity Distribution Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2023
Description of Securities Registered Under Section 12 of the Exchange Act – Talaris Therapeutics, Inc.
Registration Rights Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2022
Underwriting Agreement between Talaris Therapeutics, Inc. and Underwriters (Morgan Stanley, SVB Leerink, Evercore, Guggenheim)
Underwriting Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2021
Amended and Restated Investors' Rights Agreement among Talaris Therapeutics, Inc., Investors, and Key Holders
Investor Rights Agreements
Talaris Therapeutics, Inc.
Biotechnology
DE
2021
Common Stock Certificate for Talaris Therapeutics, Inc.
Stock Agreements
Talaris Therapeutics, Inc.
Biotechnology
2021